1. #16: Use of a Multiplex PCR Panel for Diagnosis of Complicated Pneumonia in Pediatrics. (26th March 2021) Authors: Armas, Elisa A; Melgar, M; Juárez, J; Vidal, M; Eguizábal, J; Gordillo, R Journal: Journal of the Pediatric Infectious Diseases Society Issue: Volume 10(2021)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 135PMulti-gene panel testing at the hereditary breast and ovarian cancer (HBOC) unit of the Hospital Clinic of Barcelona. (13th May 2019) Authors: Adamo, B; Moreno, L; Gaba, L; Vidal, M; Pascual, T; Chic, N; Alonso, I; Puig-Butillé, J A; Muñoz, M; Prat, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study. (23rd October 2018) Authors: Prat, A; Adamo, B; Perez Fidalgo, J A; Blanch, S; Martinez, N; Gomez Pardo, P; López González, A; Murillo Juso, L; Amillano, K; Vidal, M; Pascual, T; Pare, L; Canes, J; Galvan, P; Gonzalez Farre, B; Ortega Cebrian, V; Gonzalez, X; Bellet Ezquerra, M; Villagrasa, P; Ciruelos, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 20PERBB2 mRNA as predictor of response to anti-HER2 antibody-drug conjugates (ADC) in breast cancer (BC). (13th May 2019) Authors: Griguolo, G; Brasó-Maristany, F; Pascual, T; Chic, N; Vidal, M; Adamo, B; Giarratano, T; Dieci, M V; Guarneri, V; Prat, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 284OPrimary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study). (23rd October 2018) Authors: Pernas, S; Villagrasa, P; Vivancos, A; Scaltriti, M; Rodon, J; Burgues, O; Nuciforo, P G; Canes, J; Dueñas, M; Vidal, M; Lluch, A; Perelló, A; Llombart, A; Dorca, J; Montaño, Á; Oliveira, M; Ribas, G; Rapado, I; Prat, A; Ciruelos, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 7OPAM50MET: A prognostic model based on PAM50 and clinical variables in metastatic hormone receptor (HR)-positive/HER2 negative breast cancer. (13th May 2019) Authors: Prat, A; Tsai, Y-H; Pascual, T; Paré, L; Vidal, M; Adamo, B; Brase, J C; Johnston, S R D; Ciruelos, E M; Parker, J S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 851PPharmacokinetic/pharmacodynamic relationship of enzalutamide and its active metabolite N-desmethyl enzalutamide in metastatic castration-resistant prostate cancer patients. (23rd October 2018) Authors: Joulia, M-L; Carton Vienet Legue, E; Allard, M; Huillard, O; Peyromaure, M; Zerbib, M; Vidal, M; Goldwasser, F; Alexandre, J; Blanchet, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade. (12th October 2017) Authors: Nuciforo, P; Pascual, T; Cortés, J; Llombart-Cussac, A; Fasani, R; Paré, L; Oliveira, M; Galvan, P; Martínez, N; Bermejo, B; Vidal, M; Pernas, S; López, R; Muñoz, M; Garau, I; Manso, L; Alarcón, J; Martínez, E; Rodrik-Outmezguine, V; Brase, J C Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. An empirical model for calculation of the collimator contamination dose in therapeutic proton beams. (27th January 2016) Authors: Vidal, M; De Marzi, L; Szymanowski, H; Guinement, L; Nauraye, C; Hierso, E; Freud, N; Ferrand, R; François, P; Sarrut, D Journal: Physics in medicine & biology Issue: Volume 61:Number 4(2016:Feb.) Page Start: 1532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis. (March 2019) Authors: Garcia-Vives, E; Solé, C; Moliné, T; Alvarez-Rios, A M; Vidal, M; Agraz, I; Ordi-Ros, J; Cortés-Hernández, J Journal: Lupus Issue: Volume 28:Number 3(2019) Page Start: 396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗